10-year trajectories of depressive symptoms and risk of dementia: a population-based study

The Lancet Psychiatry

Volumn 3, Issue 7, 2016, Pages 628-635

  Mirza, Saira Saeed ^a   Wolters, Frank J ^a   Swanson, Sonja A ^a   Koudstaal, Peter J ^a   Hofman, Albert ^a   Tiemeier, Henning ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CEREBROVASCULAR ACCIDENT; DEMENTIA; DEPRESSION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; MALE; MINI MENTAL STATE EXAMINATION; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; COHORT ANALYSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; DEPRESSION; FEMALE; HUMANS; MALE; NETHERLANDS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 84975783921     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)00097-3     Document Type: Article

References (33)

1. 1 Enache, D, Winblad, B, Aarsland, D, Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24 (2011), 461–472.
2. 2 Aziz, R, Steffens, DC, What are the causes of late-life depression?. Psychiatr Clin North Am 36 (2013), 497–516.
3. 3 Kaup, AR, Byers, AL, Falvey, C, et al. Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry, 2016 published online March 16. DOI:10.1001/jamapsychiatry.2016.0004.
4. 4 Graziane, JA, Beer, JC, Snitz, BE, Chang, CH, Ganguli, M, Dual trajectories of depression and cognition: a longitudinal population-based study. Am J Geriatr Psychiatry, 2015 published Oct 22. DOI: 10.1016/j.jagp.2015.08.001.
5. 5 Dal, FG, Palermo, MT, Donohue, JE, Karagiozis, H, Zonderman, AB, Kawas, CH, Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 57 (2005), 381–387.
6. 6 Andersen, K, Lolk, A, Kragh-Sorensen, P, Petersen, NE, Green, A, Depression and the risk of Alzheimer disease. Epidemiology 16 (2005), 233–238.
7. 7 Chen, R, Hu, Z, Wei, L, Qin, X, McCracken, C, Copeland, JR, Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. Br J Psychiatry 193 (2008), 373–377.
8. 8 Saczynski, JS, Beiser, A, Seshadri, S, Auerbach, S, Wolf, PA, Au, R, Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75 (2010), 35–41.
9. 9 Hofman, A, Brusselle, GG, Darwish, MS, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 30 (2015), 661–708.
10. 10 Beekman, AT, Deeg, DJ, van Limbeek, J, Braam, AW, De Vries, MZ, van Tilburg, W, Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol Med 27 (1997), 231–235.
11. 11 Zigmond, AS, Snaith, RP, The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
12. 12 Luijendijk, HJ, van den Berg, JF, Dekker, MJ, et al. Incidence and recurrence of late-life depression. Arch Gen Psychiatry 65 (2008), 1394–1401.
13. 13 de Bruijn, RF, Bos, MJ, Portegies, ML, et al. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med, 13, 2015, 132.
14. 14 Clark, TG, Altman, DG, De Stavola, BL, Quantification of the completeness of follow-up. Lancet 359 (2002), 1309–1310.
15. 15 Deckers, K, van Boxtel, MP, Schiepers, OJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30 (2015), 234–246.
16. 16 Yaffe, K, Boustani, M, Benzodiazepines and risk of Alzheimer's disease. BMJ, 349, 2014, g5312.
17. 17 Vliegenthart, R, Geleijnse, JM, Hofman, A, et al. Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study. Am J Epidemiol 155 (2002), 332–338.
18. 18 Jones, BL, Nagin, DS, A note on a Stata plugin for estimating group-based trajectory models. Sociol Methods Res 42 (2013), 608–613.
19. 19 Proust-Lima, C, Letenneur, L, Jacqmin-Gadda, H, A nonlinear latent class model for joint analysis of multivariate longitudinal data and a binary outcome. Stat Med 26 (2007), 2229–2245.
20. 20 Swihart, BJ, Caffo, B, James, BD, Strand, M, Schwartz, BS, Punjabi, NM, Lasagna plots: a saucy alternative to spaghetti plots. Epidemiology 21 (2010), 621–625.
21. 21 Reitz, C, Bos, MJ, Hofman, A, Koudstaal, PJ, Breteler, MM, Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 39 (2008), 36–41.
22. 22 Byers, AL, Vittinghoff, E, Lui, LY, et al. Twenty-year depressive trajectories among older women. Arch Gen Psychiatry 69 (2012), 1073–1079.
23. 23 Billioti de, GS, Moride, Y, Ducruet, T, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ, 349, 2014, g5205.
24. 24 Gray, SL, Anderson, ML, Dublin, S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175 (2015), 401–407.
25. 25 Ismail, Z, Smith, EE, Geda, Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement 12 (2016), 195–202.
26. 26 Mirza, SS, de Bruijn, RF, Direk, N, et al. Depressive symptoms predict incident dementia during short- but not long-term follow-up period. Alzheimers Dement 10 (2014), S323–S329.
27. 27 Galecki, P, Talarowska, M, Anderson, G, Berk, M, Maes, M, Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. Med Sci Monit 21 (2015), 1535–1547.
28. 28 Taylor, WD, Aizenstein, HJ, Alexopoulos, GS, The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18 (2013), 963–974.
29. 29 Qiu, C, Fratiglioni, L, A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol 12 (2015), 267–277.
30. 30 Mirza, SS, de Bruijn, RF, Koudstaal, PJ, et al. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population. J Neurol Neurosurg Psychiatry 87 (2016), 356–362.
31. 31 Taylor, WD, McQuoid, DR, Payne, ME, Zannas, AS, MacFall, JR, Steffens, DC, Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry 22 (2014), 1504–1512.
32. 32 Araujo, JR, Martel, F, Borges, N, Araujo, JM, Keating, E, Folates and aging: role in mild cognitive impairment, dementia and depression. Ageing Res Rev 22 (2015), 9–19.
33. 33 Hermida, AP, McDonald, WM, Steenland, K, Levey, A, The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?. Expert Rev Neurother 12 (2012), 1339–1350.